The Clostridioides Difficile-Associated Diarrhea (Cdad) Treatment Market is a critical segment within the infectious disease space, driven by the high incidence and recurrence rates of C. difficile infection (CDI) in healthcare settings. CDI, often triggered by antibiotic use that disrupts the gut microbiome, leads to severe diarrhea and colitis. The market's robust growth reflects... https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/